in order to buy back by the same coward fund managers wbasdurds seek. ho trashed the stock in the first place. i recomend you all to sell tomorrow in order to obtain same low price as these . lets get this turd down hard.
- so the sleep market is going to move to short acting treatments to help people fall asleep and then re-dose if they wake up - ( the second part of the IR application - the middle of the night dose - remember you cannot take ambien or lunesta unless you have 8 hours or more to sleep if you wake up in the middle of the night you are toast - not so with indiplon - so i think you should go out and talk to a few docs that have older patients that have problems sleeping - the one i have talked to have told me that they try people who have taken ambien on lunesta and it almost never works and those folks are impaired in the morning - they want a shorting acting drug with the impairment or the addiction problems of ambien and lunesta - and yikes - nobody wants the cancer risk of lunesta - as you have seen 4 FDA reviewers didn't even want lunesta near the US market